Katherine Turner
Direttore/Membro del Consiglio presso Weeneebayko Area Health Authority
Profilo
Katherine Turner is currently the Director of Clinical Operations at Cognate BioServices, Inc. and also holds a Director position at Weeneebayko Area Health Authority.
Previously, she worked as a Principal at Osiris Therapeutics, Inc. from 2000 to 2002.
Turner received her undergraduate degree from Saginaw Valley State University in 1985.
Posizioni attive di Katherine Turner
| Società | Posizione | Inizio |
|---|---|---|
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Corporate Officer/Principal | - |
| Weeneebayko Area Health Authority | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Katherine Turner
| Società | Posizione | Fine |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | 02/01/2002 |
Formazione di Katherine Turner
| Saginaw Valley State University (Michigan) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Health Technology |
| Weeneebayko Area Health Authority |
- Borsa valori
- Insiders
- Katherine Turner
